Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Combination treatments (multi-target protocols often exceed single treatments)
Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
TB-500 Peptide Canada Research Summary TB-500 is a synthetic peptide representing the active region of Thymosin Beta-4, a 43-amino acid protein that is expressed in virtually all mammalian cell types
This record helps track your supply and ensures dosing consistency
US$ 25.81
US$ 21.03
US$ 27.18
US$ 29.44
US$ 26.90
